Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dyax's response for more information on DX-88 gets FDA acceptance, decision expected by Dec.
Yahoo/AP
Monday, June 8, 2009 - 10:03am
tags:
Dyax, FDA, DX-88, angioedema
Sinovac begins production of H1N1 vaccine
Marketwatch
Monday, June 8, 2009 - 9:43am
tags:
Sinovac, H1N1, vaccines
Lundbeck delays US drug application, shares dive
Reuters
Monday, June 8, 2009 - 9:37am
tags:
Lundbeck, antidepressants
Roche Plans Phase III Study On Diabetes Drug Aleglitazar
WSJ Online
Monday, June 8, 2009 - 9:34am
tags:
Roche, diabetes, drug trials, Aleglitazar
Alnylam, Cubist: Drug meets midstage safety goals
Yahoo/AP
Monday, June 8, 2009 - 9:30am
tags:
Alnylam, Cubist Pharmaceuticals, drug trials, ALN-RSV01
Micromet's lead drug meets midstage study goal
Yahoo/AP
Monday, June 8, 2009 - 8:44am
tags:
Micromet, blinatumomab, leukemia
Gilead Looks Good on Strong Sales and Pipeline
Seeking Alpha
Monday, June 8, 2009 - 8:42am
tags:
Gilead Sciences, HIV, tenofovir
What Does Seth Klarman See in Facet Biotech?
Seeking Alpha
Monday, June 8, 2009 - 8:26am
tags:
Facet Biotech
ChemGenex Says Leukemia Drug Kills Cancer Stem Cells in Study
Bloomberg
Monday, June 8, 2009 - 8:24am
tags:
ChemGenex, leukemia
Novartis saw positive results from Afinitor trial
Marketwatch
Monday, June 8, 2009 - 8:23am
tags:
Novartis, Afinitor
Study Shows GSK's Novel Diabetes Treatment SYNCRIA(R) (albiglutide) Improves Glucose Control and Reduces Weight
Yahoo/PR Newswire
Sunday, June 7, 2009 - 11:39am
tags:
GSK, Syncria, diabetes
Health Care Trends Part 2: M&A, Generic Competition, CROs
Seeking Alpha
Sunday, June 7, 2009 - 11:38am
tags:
Interim Study Results Presented at ADA 2009: Exenatide Not Associated With Increased Rate of Acute Pancreatitis Compared to Other Antidiabetic Drugs
Yahoo/PR Newswire
Sunday, June 7, 2009 - 11:36am
tags:
Amylin, Eli Lilly, Byetta, diabetes
Biggest Healthcare Winners Become Biggest Losers After Friday's Market Action
Seeking Alpha
Sunday, June 7, 2009 - 11:35am
tags:
New Study Shows Nplate(R) Significantly Reduces Splenectomy Rate and Treatment Failure in Patients With Chronic ITP
PR NewsWire
Sunday, June 7, 2009 - 11:34am
tags:
Nplate, Amgen
China Biotech in Review: Entering a New Phase?
Seeking Alpha
Sunday, June 7, 2009 - 11:32am
tags:
China, biotech
Pfizer - Hemas launch two new products (in India)
Financial Times, UK
Sunday, June 7, 2009 - 11:07am
tags:
Pfizer, Hemas
OctoPlus wins new drug delivery evaluation contract for two compounds
PR-Canada, Canada
Sunday, June 7, 2009 - 10:32am
tags:
OctoPlus
Lilly: positive results on diabetes treatment
MarketWatch
Sunday, June 7, 2009 - 9:29am
tags:
Eli Lilly, diabetes
Interim Analysis of Long-Term Data with ONGLYZA (saxagliptin) When Added to Metformin in People with Inadequately Controlled Type 2 Diabetes Presented at ADA Annual Scientific Sessions
Yahoo/Business Wire
Sunday, June 7, 2009 - 8:55am
tags:
Bristol-Myers Squibb, AstraZeneca, Onglyza, diabetes

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.